Cargando…
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
Interactions between sialylated glycans and sialic acid-binding immunoglobulin-like lectin (Siglec) receptors have been recently described as potential new immune checkpoint that can be targeted to improve anticancer immunity. Myeloid cells have been reported to express a wide range of different Sig...
Autores principales: | Wang, Jinyu, Manni, Michela, Bärenwaldt, Anne, Wieboldt, Ronja, Kirchhammer, Nicole, Ivanek, Robert, Stanczak, Michal, Zippelius, Alfred, König, David, Rodrigues Manutano, Natalia, Läubli, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927547/ https://www.ncbi.nlm.nih.gov/pubmed/35309936 http://dx.doi.org/10.3389/fcell.2022.828916 |
Ejemplares similares
-
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events
por: Müller, Benjamin, et al.
Publicado: (2023) -
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses
por: Kashyap, Abhishek S., et al.
Publicado: (2019) -
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
por: Stanczak, Michal A., et al.
Publicado: (2022) -
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020) -
Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade
por: Läubli, Heinz, et al.
Publicado: (2017)